With 92 full-time primary faculty, 30 dual-appointment faculty, 75 voluntary faculty and 41 residents and fellows in training, the Keck USC Department of Pathology is one of the largest pathology departments in the United States. The Department provides diagnostic laboratory services for the LAC+USC Medical Center, the USC University and Norris Cancer Hospitals, the Doheny Eye Institute, and through its reference laboratories, the USC Clinical Laboratory Group.
Pathology is a study of disease: its etiology, pathogenesis and pathophysiology, and its morphologic expression at organ, tissue, cellular and ultrastructural levels. The spectrum of research interests of our faculty includes basic molecular mechanisms of cell function and vertebrate development, as well as translational studies on disease mechanism, diagnosis and treatment. Pathology is a medical specialty that provides the scientific foundation for all medical practice. The pathologist works with each of the clinical specialties, using the tools of laboratory medicine to provide information essential to problem solving in clinical practice. As such, the pathologist is the "doctors' doctor."
Pathology is the only discipline that can be classified as both a basic and clinical science. As such, it provides for our medical students an indispensable bridge between the basic science and the clinical relevance and application of this information. Pathology provides a rich environment for graduate education in which our students can receive comprehensive training in as many areas of both the basic and clinical sciences as they relate to pathologic mechanisms.
Featured Event
There are no event items at this time, please check back soon.
Featured News
Dr. Michael Lieber is among several USC Norris Comprehensive Cancer Center researchers who have made important discoveries in the 40 years since the National Cancer Act was passed.
Read The Full Story
More Upcoming Events
5:00pm PT
Norris Cancer Center, Topping Tower, Room 7409
8:00am PT
LAC+USC Clinic Tower, Room A7A
8:00am PT
LAC+USC Clinic Tower, Room A7A
8:00am PT
LAC+USC Clinic Tower, Room A7A
8:00am PT
LAC+USC Clinic Tower, Room A7A
8:00am PT
LAC+USC Clinic Tower, Room A7A
View All Events
More News
-
Scientists from the Keck School of Medicine of USC have discovered the first gene associated with autism that has genome-wide significance. The discovery, detailed in the April 4 edition of the journal Science Translational Medicine, may allow researchers to study the causes of autism and develop new treatments for the disorder more effectively.
Read The Full Story
-
Minorities with cancer may be more susceptible to complications of the disease, especially when obesity comes into play, according to research presented by a Keck School of Medicine professor at the American Association for Cancer Research (AACR) Annual Meeting 2012.
Read The Full Story
-
Researchers at the Keck School of Medicine of USC have identified a potential new drug target for hepatocellular carcinoma, the most common form of liver cancer in adults.
Read The Full Story
-
A global team of microbiologists led by the Keck School of Medicine has identified a critical protein in the fight against bacterial and fungal infections like tuberculosis and ringworm, laying the groundwork for scientists to develop target-specific drugs that have fewer side effects.
Read The Full Story
-
Keck School of Medicine of USC researchers have singled out the rat mesenchymal stem cell as an effective cell model to study the virus that causes Kaposi’s sarcoma, the most common cancer among AIDS patients.
Read The Full Story
-
An international team of researchers led by Chaim O. Jacob, M.D., Ph.D., associate professor of medicine and microbiology & immunology at the Keck School of Medicine of the University of Southern California, has identified a gene mutation involved in causing lupus, a chronic inflammatory disease that affects the skin, joints and organs.
Read The Full Story
-
The USC Norris Comprehensive Cancer Center looks back on important discoveries and breakthroughs made at the center in the 40 years since the National Cancer Act was passed, on Dec. 23, 1971.
Read The Full Story
View All News